We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Reposting for new investors GLA
Star knight, stop reposting, you are becoming annoying. New investors can scroll down. This should finish around 60p today. GLA
Reposting for new investors GLA
Reposting for new investors GLA
I would congratulate SK on a post without an all caps title....but I'm pretty sure he just copy and pasted it, so doesn't really count.
Professor Carl Smythe, Sheffield University, Paraytec, Astra Zeneca, Fujitsu do the maths its all there for you..!!!
Just got info the manufacturers and the companies are more alert and desperate compared to investors. Can't wait to bring the results to the market. Time is the treasure. Once breaking £1 again for the third time then £2 is not the dreamer. Share prices steadily rose, confirming more buyers to hold longer and lack of sellers towards over a pound now.
SK whats in your posts just says reminder with no info???
Reposting for new investors GLA
The development of our fast and sensitive COVID-19 test project uses a combination of existing intellectual property previously developed by Paraytec and also the creation of a wide range of new intellectual property within the fields of biochemistry, equipment hardware and software. Paraytec has employed specialist patent lawyers to assist with developing a pathway for the protection of the intellectual property and know how that has been developed during the creation of our COVID-19 test and to ensure that all novel intellectual property is protected by patents. Paraytec currently has a suite of five core patents granted and a further three patent applications submitted. Paraytec expects to be filing further additional patent applications over the first two quarters of 2021 as it develops the intellectual property around the COVID-19 test project.
So as our Paraytec device very closely conforms to the MHRA specifications I do not think it will be long before our device is brought to market (GLOBAL MARKET) with all required regulatory requirements!
Target Product Profile: Point of Care SARS-CoV-2 Detection Tests
PARAYTEC COVID-19 OPTICAL MEASUREMENT TEST
Here is the latest update 23rd March 2021 of the MHRA Target Product Profile (TPP) for a portable SARS-COV-2 Detection Test published by the UK Government MHRA Regulatory agency
This state the requirements of the MHRA to assist manufacturers to design and deliver tests that might be useful in support of the UK COIVD-19 testing strategy.
When compared with the brief description of our Paraytec Covid-19 Optical Test Device the specifications are very close and indeed the Paraytec specifications are more optimal in my opinion.
Link to MHRA Target Product Profile: Point of Care SARS-CoV-2 Detection Tests
https://www.gov.uk/government/publications/how-tests-and-testing-kits-for-coronavirus-covid-19-work/target-product-profile-point-of-care-sars-cov-2-detection-tests
PARAYTEC COVID-19 OPTICAL TEST
Designed to give a portable test, which can generate a result in a matter of 5 to 10 minutes (being revised) from a swab provided at the test location and which requires no specialist skills for its operation. It is anticipated that this product will be used in locations where the rapid screening of large numbers of people for presence of COVID-19, or any future emerging pandemic is required.
The key attributes for the testing device that we have determined are as follows:
• Simple swab or saliva sample – no clinical expertise needed
• No complex sample preparation – proprietary single-use cartridge containing analytes
• Simple portable reader – shoebox size
• No clinical training needed – automated test can be used in any location
• Rapid result – sample to result in 5 to 10 minutes, potential for further reduction
• yes/no result – option for quantification of viral load
• Platform technology – can potentially be used to detect multiple virus targets
Paraytec Scientific Concept
The test involves the deployment of a DNA aptamer – a short, single-stranded DNA molecule that adopts a shape that is complementary to that of the virus surface protein. By coating a test surface with millions of copies of the aptamer molecule, Paraytec’s CAPTURE module can trap Covid-19 virus particles from a swab sample, as they flow over the test surface. Trapped viruses are then instantaneously coated with the SIGNAL GENERATION module, a synthetic chimeric protein, that both recognises the viral surface as well as being highly fluorescent. The resultant fluorescent signal is measured by the novel DETECTION system developed using the company’s proprietary expertise in optics, electronics and software.
Continued